3 Stocks That Quadrupled
The stock market continues to put on a clinic about how to stomp all over expectations. The Dow Jones Industrial Average is up 25% this year and the S&P 500 is 20% higher, but stack them up next to Nektar Therapeutics (NASDAQ: NKTR), Esperion Therapeutics (NASDAQ: ESPR), and Sangamo Therapeutics (NASDAQ: SGMO), and the market index returns look quaint.
Let's look more closely at these three biotechs to see whether there's any more room to run after quadrupling so far in 2017.
Source: Fool.com
Sangamo Therapeutics Inc. Stock
€0.74
0.280%
Currently there is a rather negative sentiment for Sangamo Therapeutics Inc. with 11 Buy predictions and 15 Sell predictions..
However, we have a potential of 304.97% for Sangamo Therapeutics Inc. as the target price of 3 € is above the current price of 0.74 €.